DORADO: opportunity postponed: lessons from studies of endothelin receptor antagonists in treatment-resistant hypertension
- PMID: 20921424
- DOI: 10.1161/HYPERTENSIONAHA.110.160952
DORADO: opportunity postponed: lessons from studies of endothelin receptor antagonists in treatment-resistant hypertension
Comment on
-
Divergent results using clinic and ambulatory blood pressures: report of a darusentan-resistant hypertension trial.Hypertension. 2010 Nov;56(5):824-30. doi: 10.1161/HYPERTENSIONAHA.110.156976. Epub 2010 Oct 4. Hypertension. 2010. PMID: 20921430 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources